Genetic polymorphisms in  TNIP1  increase the risk of gastric carcinoma

Zhao Liu; Yuting Shi; Yuyan Na; Qi Zhang; Sizhe Cao; Xianglong Duan; Xiyang Zhang; Hua Yang; Tianbo Jin; Yiming Li

doi:10.18632/oncotarget.9637

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Genetic polymorphisms in TNIP1 increase the risk of gastric carcinoma

Zhao Liu _, Yuting Shi, Yuyan Na, Qi Zhang, Sizhe Cao, Xianglong Duan, Xiyang Zhang, Hua Yang, Tianbo Jin and Yiming Li

PDF | HTML | How to cite

Oncotarget. 2016; 7:40500-40507. https://doi.org/10.18632/oncotarget.9637

Metrics: PDF 1473 views | HTML 1962 views | ?

Abstract

Zhao Liu1,2, Yuting Shi3, Yuyan Na4, Qi Zhang5, Sizhe Cao5, Xianglong Duan6, Xiyang Zhang7, Hua Yang7, Tianbo Jin7, Yiming Li1

1Department of General Surgery, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710004, China

2Department of Surgery, Xi'an Chest Hospital, Xi'an TB&Thoracic Tumor Hospital, Xi'an 710100, China

3Department of Medical Oncology, Graduate School of Inner Mongolia Medical University, Hohhot 010000, China

4Department of Pediatric Orthopedics, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010030, China

5Department of Medical, Xi'an Chest Hospital, Xi'an TB&Thoracic Tumor Hospital, Xi'an 710100, China

6Second Department of General Surgery, Shaanxi Province People's Hospital, Xi’an 710001, China

7Department of Biochemistry, School of Life Sciences, Northwest University, Xi’an 710069, China

Correspondence to:

Yiming Li, email: [email protected]

Keywords: gastric carcinoma, single nucleotide polymorphisms (SNPs), TNF-α-induced protein 3-interacting protein 1 (TNIP1), case-control study

Received: March 30, 2016 Accepted: May 13, 2016 Published: May 26, 2016

ABSTRACT

The distribution and levels of TNIP1 in malignant and normal gastric mucosa are different, but it is not known whether TNIP1 polymorphisms are related to gastric carcinogenesis. To assess the association between four TNIP1 SNPs (rs3792792, rs4958881, rs7708392, rs10036748) and carcinogenesis, we used Sequenom Mass-ARRAY technology to determine the genotypes of 302 gastric carcinoma patients and 300 healthy controls in a Northwest Chinese Han population. These data were then compared using the Chi-square test/Fisher's exact test, genetic model analysis, and haplotype analysis. Odds ratios (OR) and 95% confidence intervals (CI) were used to evaluate the correlation. We observed that patients with the “G” allele of rs7708392 and the “C” allele of rs10036748 showed an increased risk of gastric carcinoma (OR= 1.335, 95%CI: 1.021-1.745, P= 0.035; OR= 1.358, 95%CI: 1.039-1.774, P= 0.025, respectively). Conversely, the haplotype “CT” of TNIP1 (rs7708392-rs10036748) may act as a genetic protective factor for gastric carcinoma (adjusted OR= 0.731, 95%CI: 0.552-0.970, P= 0.030). Our results are the first to suggest that genetic variation in TNIP1 gene is associated with gastric carcinoma, though, this finding must be confirmed in other populations with larger sample size.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9637

Publication Alerts

Research Papers:

Genetic polymorphisms in TNIP1 increase the risk of gastric carcinoma

Abstract